查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1702038

2025 年至 2033 年抗感染药物市场报告（按类型、给药途径（局部、口服、静脉注射等）、配销通路和地区划分）

Anti-infectives Market Report by Type, Route of Administration (Topical, Oral, Intravenous, and Others), Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球抗感染药物市场规模达 1,388 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 1,800 亿美元，2025-2033 年期间的成长率 (CAGR) 为 2.93%。

抗感染药物是透过抑制传播或直接杀死传染源来对抗感染的药物。这些药物包括抗生素、抗病毒药、抗霉菌药、抗疟药、驱虫药和抗原虫药。它们通常透过口服、肠胃外和局部途径给药。它们被广泛用于治疗轻微传染病，包括肺炎和结核病。除此之外，在剖腹产和关节置换等常规手术中也会使用抗感染药物，这些手术具有很高的严重感染风险。

抗感染药物市场趋势：

全球抗感染药物市场主要受到全球传染病发生率上升的推动。反不定式用于治疗感染，包括病毒、细菌、寄生虫和真菌。此外，采用不同策略配製的新型药物（如天然产物、群体感应抑制剂、生物膜破坏剂、镓基药物、环糊精抑制剂和基于光的抗菌剂）的开发正在为市场成长提供动力。与此相符的是，药物发现程序的最新创新，例如干细胞和器官晶片（OOC）技术，旨在加强药物试验过程，为市场创造积极的前景。此外，由于 COVID-19 疾病的出现以及曲霉病、侵袭性念珠菌病和毛霉菌病等诱发感染，产品采用率不断提高，这也增强了市场的成长。除此之外，监管机构批准的新型抗感染药物数量不断增加也是另一个促进成长的因素。此外，预计政府优惠政策的实施、对开发新型创新药物的投资增加、个人对传染病认识的提高以及医疗保健基础设施的快速改善将在未来几年推动市场的成长。

本报告回答的关键问题

  • 2024 年全球抗感染药物市场规模？ 2025-2033年全球抗感染药物市场的预期成长率是多少？
  • 推动全球抗感染药物市场发展的关键因素有哪些？
  • COVID-19 对全球抗感染药物市场有何影响？
  • 全球抗感染药物市场按类型划分是怎样的？
  • 根据给药途径，全球抗感染药物市场如何分布？
  • 根据配销通路，全球抗感染药物市场分布如何？
  • 全球抗感染药物市场的主要区域有哪些？
  • 全球抗感染药物市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球抗感染药物市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 抗菌
  • 抗真菌
  • 抗病毒剂

第七章：市场区隔：依行政途径

  • 外用
  • 口服
  • 静脉注射（IV）
  • 其他的

第八章：市场区隔：按配销通路

  • 医院药房
  • 零售药局
  • 专业药房
  • 网上商店
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Cipla Health Ltd. (Cipla Limited)
    • F. Hoffmann-La Roche AG
    • GlaxoSmithKline plc
    • Glenmark Pharmaceuticals Limited
    • Johnson & Johnson
    • Lupin Limited
    • Sandoz AG (Novartis AG)
    • Sun Pharmaceutical Industries Limited
Product Code: SR112025A6073

The global anti-infectives market size reached USD 138.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 180.0 Billion by 2033, exhibiting a growth rate (CAGR) of 2.93% during 2025-2033.

Anti-infectives are medicines that act against infections, either by inhibiting the spread or killing the infectious agent outright. These medicines include antibiotics, antivirals, antifungals, antimalarials, anthelmintics, and antiprotozoals. They are generally administered through oral, parenteral, and topical routes. They are widely used to treat minor infectious diseases, including pneumonia and tuberculosis. Apart from this, anti-infectives are also utilized during routine procedures and surgeries, such as cesarian section and joint replacement, which are associated with a high risk of severe infection.

Anti-infectives Market Trends:

The global anti-infectives market is primarily driven by rising incidences of infectious diseases across the globe. Anti-Infinitives are used to treat infections, including viruses, bacteria, parasites, and fungi. Additionally, the development of novel drugs that are formulated using different strategies, such as natural products, quorum sensing inhibitors, biofilm disruptors, gallium-based drugs, cyclodextrin inhibitors, and light-based antimicrobials, are providing an impetus to the market growth. In line with this, the latest innovations in drug discovery procedures, such as stem cells and organ-on-chip (OOC) technologies, to enhance drug trial processes are creating a positive outlook for the market. Furthermore, the increasing product adoption due to the advent of the COVID-19 disease and induced infections, such as aspergillosis, invasive candidiasis, and mucormycosis, is strengthening the growth of the market. Besides this, the increasing number of new anti-infective drugs being approved by the regulatory authorities is acting as another growth-inducing factor. Moreover, the implementation of favorable government policies, rising investments in developing new and innovative drugs, increasing awareness among individuals about infectious diseases, and rapidly improving healthcare infrastructure are anticipated to impel the growth of the market in the coming years.

Key Market Segmentation:

Breakup by Type:

  • Antibacterial
  • Antifungal
  • Antiviral

Breakup by Route of Administration:

  • Topical
  • Oral
  • Intravenous (IV)
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Speciality Pharmacies
  • Online Stores
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Cipla Health Ltd. (Cipla Limited), F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Johnson & Johnson, Lupin Limited, Sandoz AG (Novartis AG) and Sun Pharmaceutical Industries Limited.

Key Questions Answered in This Report

  • 1.What was the size of the global anti-infectives market in 2024?
  • 2.What is the expected growth rate of the global anti-infectives market during 2025-2033?
  • 3.What are the key factors driving the global anti-infectives market?
  • 4.What has been the impact of COVID-19 on the global anti-infectives market?
  • 5.What is the breakup of the global anti-infectives market based on the type?
  • 6.What is the breakup of the global anti-infectives market based on the route of administration?
  • 7.What is the breakup of the global anti-infectives market based on distribution channel?
  • 8.What are the key regions in the global anti-infectives market?
  • 9.Who are the key players/companies in the global anti-infectives market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Anti-infectives Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Antibacterial
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Antifungal
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Antiviral
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Topical
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Intravenous (IV)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Speciality Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Stores
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Cipla Health Ltd. (Cipla Limited)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 F. Hoffmann-La Roche AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 GlaxoSmithKline plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Glenmark Pharmaceuticals Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Lupin Limited
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Sandoz AG (Novartis AG)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Sun Pharmaceutical Industries Limited
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Anti-infectives Market: Major Drivers and Challenges
  • Figure 2: Global: Anti-infectives Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Anti-infectives Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Anti-infectives Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Anti-infectives Market: Breakup by Route of Administration (in %), 2024
  • Figure 6: Global: Anti-infectives Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Anti-infectives Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Anti-infectives (Antibacterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Anti-infectives (Antibacterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Anti-infectives (Antifungal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Anti-infectives (Antifungal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Anti-infectives (Antiviral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Anti-infectives (Antiviral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Anti-infectives (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Anti-infectives (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Anti-infectives (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Anti-infectives (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Anti-infectives (Intravenous (IV)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Anti-infectives (Intravenous (IV)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Anti-infectives (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Anti-infectives (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Anti-infectives (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Anti-infectives (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Anti-infectives (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Anti-infectives (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Anti-infectives (Speciality Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Anti-infectives (Speciality Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Anti-infectives (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Anti-infectives (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Anti-infectives (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Anti-infectives (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: North America: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: North America: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: United States: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: United States: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Canada: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Canada: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Asia-Pacific: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Asia-Pacific: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: China: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: China: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Japan: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Japan: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: India: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: India: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: South Korea: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: South Korea: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Australia: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Australia: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Indonesia: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Indonesia: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Others: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Others: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Europe: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Europe: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Germany: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Germany: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: France: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: France: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: United Kingdom: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: United Kingdom: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Italy: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Italy: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Spain: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Spain: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Russia: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Russia: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Latin America: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Latin America: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Brazil: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Brazil: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Mexico: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Mexico: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Middle East and Africa: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Middle East and Africa: Anti-infectives Market: Breakup by Country (in %), 2024
  • Figure 80: Middle East and Africa: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Global: Anti-infectives Industry: SWOT Analysis
  • Figure 82: Global: Anti-infectives Industry: Value Chain Analysis
  • Figure 83: Global: Anti-infectives Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Anti-infectives Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Anti-infectives Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Anti-infectives Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 4: Global: Anti-infectives Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Anti-infectives Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Anti-infectives Market: Competitive Structure
  • Table 7: Global: Anti-infectives Market: Key Players